The impaired Jag1 processing induced by anti-Jag1 antibodies is also accompanied by reduction in IL-4-induced CLL cell viability, suggesting that Jag1 processing may be one of the events whereby IL-4 promotes CLL cell survival. The gene discussed is JAG1; the disease is B-cell chronic lymphocytic leukemia.